AVEO Pharmaceuticals (AVEO) Prices Offering at $7.50/Sh

Article Related Press Releases (1) Stock Quotes (1) Comments (0)

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) announced the pricing of an underwritten public offering of 6,667,000 shares of its common stock at a price of $7.50 per share to the public.

All of the shares are being sold by AVEO.

The gross proceeds to AVEO from this offering are expected to be approximately $50.0 million, before deducting underwriting discounts and commissions, and other estimated offering expenses payable by AVEO.

J.P. Morgan Securities LLC is acting as sole book-running manager for the offering, with RBC Capital Markets, LLC and Canaccord Genuity Inc. acting as co-lead managers.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures
• Sensata (ST) Announces 12.5M Common Share Secondary Offering
• Bloomin' Brands (BLMN) Prices 19M Common Stock Secondary Offering

Create E-mail Alert Related Categories

Equity Offerings

Related Entities

JPMorgan, RBC Capital, Canaccord Genuity

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?